Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern Italy
Author:
Affiliation:
1. Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Naples, Italy
Publisher
Informa UK Limited
Subject
Dermatology
Link
https://www.tandfonline.com/doi/pdf/10.1080/09546634.2020.1769828
Reference4 articles.
1. Efficacy and safety of biosimilar rituximab in the treatment of pemphigus vulgaris: a single center experience of 12 cases
2. Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears
3. The impact of the COVID ‐19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review;Clinical, Cosmetic and Investigational Dermatology;2024-01
2. Management Strategies for Pediatric Moderate-to-Severe Plaque Psoriasis: Spotlight on Biologics;Pediatric Health, Medicine and Therapeutics;2023-11
3. Hidradenitis suppurativa perspectives during the COVID-19 pandemic;Clinics in Dermatology;2023-09
4. Advanced Squamous Cell Carcinoma Developed on Chronic Hidradenitis Suppurativa, Successfully Treated with Cemiplimab: A Case Report;Case Reports in Dermatology;2023-02-14
5. Anti-IL23 biologic therapies in the treatment of psoriasis: real-world experience versus clinical trials data;Immunologic Research;2023-01-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3